Emergent BioSolutions to Participate in Investor Conferences

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) announced participation in upcoming investor conferences. The company will hold 1-on-1 meetings at the Goldman Sachs Credit and Leveraged Finance Conference on May 17, 2021, and at the Benchmark Company Healthcare House Call Conference on May 26, 2021. Additionally, a company presentation is scheduled during the Singular Research Spring Select Webcall on May 27, 2021, at 8:00 am Pacific / 11:00 am Eastern. Webcast presentations will discuss recent business developments and financial results, accessible live and via replay on the Emergent website.

GAITHERSBURG, Md., May 05, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:

• Goldman Sachs Credit and Leveraged Finance Conference
  May 17, 2021
  1-on-1 meetings only

• Benchmark Company Healthcare House Call Conference
  May 26, 2021
  1-on-1 meetings only

• Singular Research Spring Select Webcall
  May 27, 2021
  Company presentation scheduled at 8:00 am Pacific / 11:00 am Eastern

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcast will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com  

Media Contact:
Matt Hartwig
Director, Media Relations
hartwigm@ebsi.com

FAQ

What conferences is Emergent BioSolutions participating in May 2021?

Emergent BioSolutions is attending the Goldman Sachs Credit and Leveraged Finance Conference on May 17, the Benchmark Company Healthcare House Call Conference on May 26, and the Singular Research Spring Select Webcall on May 27, 2021.

When is Emergent BioSolutions' presentation at the Singular Research Conference?

The presentation by Emergent BioSolutions at the Singular Research Spring Select Webcall is scheduled for May 27, 2021, at 8:00 am Pacific / 11:00 am Eastern.

Will Emergent BioSolutions provide a live webcast during the investor conferences?

Yes, Emergent BioSolutions will offer live webcasts for its presentations during the conferences, with replays available on its website.

What will Emergent BioSolutions discuss during its presentations?

During the presentations, Emergent BioSolutions will discuss recent business developments and provide insights into its financial results and guidance.